https://www.selleckchem.com/pr....oducts/epacadostat-i
After persistent symptoms, nebulized TXA at a dose of 500 mg three times a day was administered. The patients were all discharged from the hospital with improvement in their symptoms. Tranexamic acid may be considered in the treatment of hemoptysis regardless of the underlying cause. This may be utilized pending further workup and investigation into the underlying source of the bleeding. Tranexamic acid may be considered in the treatment of hemoptysis regardless of the underlying cause. This may be utilized pending furthe
Beğen
Yorum Yap
Paylaş
